Conozca en Tiempo Real las estadísticas de casos de COVID-19 y vacunación en Puerto Rico.
Pfizer- Biontech confirmó que su Vacuna en menores de 12 a 15 años es 100% eficaz
Tras los ensayos de la fase 3 en adolescentes con edades entre 12 y 15 años los resultados demostraron una eficacia del 100% según confirmó Pfizer junto a Biontech. 
Doctor Carlos Mendez, oncólogo del hospital Hima de Caguas
Continúan avanzando los tratamientos contra el cáncer de colon en Puerto Rico
El cáncer de colon en Puerto Rico ha mejorado en el diagnóstico y la prognosis siendo un cáncer retante hace 2 o 3 décadas. Hoy día gracias a los tratamientos específicos los pacientes... 
Más de un millón de personas han sido vacunadas contra el COVID-19 en Puerto Rico
El secretario del Departamento de Salud (DS), Carlos Mellado López, confirmó que sobrepasamos el millón de dosis administradas en Puerto Rico para frenar la pandemia del COVID-19.
'Strong immune response' from one dose of Pfizer vaccine: study
People previously infected with SARS-CoV-2 showed higher antibody and T-cell responses after one dose of Pfizer's BNT162b2 messenger (mRNA) vaccine compared with people who had a first dose without... 
CMS Facing Pressure to Add Telehealth to Diabetes Prevention Programs
The Alliance for Connected Care is leading a new lobbying effort to have telehealth included in the Medicare Diabetes Prevention Program, both during and after the COVID-19 public health emergency.
COVID-19: for health care workers, lost sleep and burnout are risk factors
Sleep problems and burnout among frontline health care workers may be risk factors for COVID-19. 
Rare ‘Breakthrough’ Cases of COVID-19 Are Occurring in Vaccinated People
The number of people being vaccinated against COVID-19 is increasing every day in the United States. On average, more than 2.8 million people are being vaccinated against the disease every day.
Dynamic model of SARS-CoV-2 spike protein reveals potential new vaccine targets
A new, detailed model of the surface of the SARS-CoV-2 spike protein reveals previously unknown vulnerabilities that could inform development of vaccines.
Monoclonal antibodies for COVID-19: What do we know so far?
As countries continue to roll out vaccines to prevent COVID-19 and achieve herd immunity, scientists continue to work on developing treatments for the disease.